glp 1 telehealth Pharma Turns to Direct-to-Consumer Telehealth: A Game Changer for GLP-1 Drug Marketing Were you getting GLP-1 weight-loss
Description
LeuchtSWinter-van RossumIHeresSArangoCFleischhackerWWGlenthojBet al
Can the titration be sped up to lose weight faster
Mittendorf T, Smith-Palmer J, Timlin L, Happich M, Goodall G
doi: 10.1007/s00125-009-1532-3

Individuals taking a GLP-1 receptor agonist were 9.1 times more likely to experience pancreatitis, 4.2 times more likely to have a bowel obstruction, and 3.7 times more likely to have gastroparesis compared to patients taking another type of drug

Recent Findings Beyond weight reduction, GLP-1RAs have shown positive cardiovascular outcomes in patients with elevated ASCVD risk, heart failure with preserved ejection fraction, obstructive sleep apnea, blood pressure, and dyslipidemia
